Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants

Tundra lists 1 Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06846437

JSKN003 Versus Trastuzumab Emtansine (T-DM1) for HER2-Positive, Advanced Breast Cancer

This study is designed to compare the safety and efficacy of JSKN003 versus T-DM1 in unrespectable locally advanced and/or metastatic HER2-positive breast cancer participants previously treated with trastuzumab and taxane.

Gender: All

Ages: 18 Years - Any

Updated: 2025-03-24

Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants